Voloridge Investment Management
TSVT

Voloridge Investment Management’s 2seventy bio TSVT Stock Holding History

Voloridge Investment Management’s Portfolio TSVT Stock Details TSVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-29,663
Closed -$303K – 1570
2023
Q1 		$303K Buy
+29,663
New +$339K ﹤0.01% 1276

Other funds holding TSVT

KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Voloridge Investment Management's TSVT Position: Q2 2023 in Review

Voloridge Investment Management sold out of 2seventy bio (TSVT) in Q2 2023, closing a stake of 29,663 shares — an estimated $303K sold.

Voloridge Investment Management first reported a position in TSVT in Q1 2023 and held it in 1 quarter. The position peaked at $303K in Q1 2023. 150 funds tracked by Wall St. Rank hold TSVT as of Q2 2023.

  • Voloridge Investment Management reported no remaining 2seventy bio position as of Q2 2023 after selling out during the quarter.
  • Voloridge Investment Management sold 29,663 2seventy bio shares in Q2 2023, an estimated $303K.
  • Voloridge Investment Management first reported a position in 2seventy bio in Q1 2023 and held it in 1 quarter.
  • Voloridge Investment Management's 2seventy bio position peaked at $303K in Q1 2023.
  • 150 funds tracked by Wall St. Rank held 2seventy bio as of Q2 2023.

Based on Voloridge Investment Management's 13F filing for Q2 2023, filed 14 Aug 2023.